Tongrentang's Shiyi Qingwen Pill Receives Canadian Product License

财中社··Read original
2▲2 ▼0Impact / 5
Summary · why it matters

Tongrentang's subsidiary, Tongrentang Pharmaceutical Factory, has obtained a Class III Product License approved and issued by Health Canada, with its product Shiyi Qingwen Pill (water-honeyed pill) receiving Canadian product registration. The product's indications are based on a combination of traditional Chinese medicine ingredients, used for clearing heat, releasing the exterior, and relieving heat toxicity. In the first quarter of 2026, Tongrentang achieved revenue of 4.664 billion yuan and net profit attributable to the parent company of 471 million yuan.

Impact on assets 2

Health Care▲
Others▲
Beijing Tongrentang Co Ltd
600085
▲ PositiveRegulationrelevance

Beijing Tongrentang's subsidiary obtained Canadian product license for Shiyi Qingwen Pill, enabling market access.